Gene switches have piqued the interest of adoptive cell therapy developers owing to their ability to enhance safety and control the activity of genetically modified cell products in vivo, while sparing the host immune activity

Roots Analysis is pleased to announce the publication of its recent study, titled, “Gene Switch Market, 2023-2035”

The study features an extensive study of the current market landscape and future opportunity for the players focused on the development of gene switch platforms. Amongst other elements, the report features:

• A general overview of gene switches, highlighting details on the basic components of a gene switch and its mechanism of action. It also presents information on the applications and challenges associated with gene switches. In addition, it features a discussion on the future prospects within this domain
• A detailed assessment of the current market landscape of gene switch platforms that are under development, based on several relevant parameters
• A product competitiveness analysis of the gene switch platforms, based on supplier power and product competitiveness
• Elaborate profiles of prominent players (shortlisted based on a proprietary criterion) engaged in gene switch domain
• An analysis of the partnerships that have been inked by stakeholders engaged in this domain, since 2019
• An in-depth analysis of the funding and investments that have been made into companies having proprietary gene switch/molecular switch platforms
• A detailed analysis of peer-reviewed scientific articles related to research on gene switches, over the last five years
• An in-depth analysis of the patents that have been filed / granted related to gene switches, since 2017
• A detailed analysis of various business models adopted by the firms developing gene switch platforms, including operational model, service centric model and product centric model
• A detailed market forecast for gene switch platforms, featuring analysis of the current and projected future opportunity across key market segments (listed below):
• Application Area
• Management of Treatment Related Toxicity
• Regulation of Gene Expression
• Other Applications

• Type of Target Therapy
• CAR-T cell Therapies
• Gene therapies
• Other Therapies

• Type of Payment Model Employed
• Upfront Payment
• Milestone Payment

• Key Geographical Regions 
• North America
• Europe
• Asia Pacific

Rest of the World 

Key companies covered in the report

• aceRNA technologies
• Autolus Therapeutics
• Bellicum Pharmaceuticals
• Cellectis
• Kiromic BioPharma
• panCELLa
• Precigen
• Sana Biotechnology
• Sangamo Therapeutics

To view more details on this report, click on the link

https://www.rootsanalysis.com/reports/gene-switch-market.html

Learn from experts:  do you know about these emerging industry trends?

Unlocking the Potential of Digital Twins in Healthcare: Benefits, Challenges and Opportunities

At-home Self-testing: A Giant Leap Towards Transformation in Diagnostic Sector

Learn from our recently published whitepaper:-
Next Generation Biomanufacturing – The Upcoming Era of Digital Transformation

About Roots Analysis

Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

Learn more about Roots Analysis consulting services: 

Roots Analysis Consulting - the preferred research partner for global firms

Contact:

Ben Johnson

+1 (415) 800 3415

Ben.johnson@rootsanalysis.com